Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Meta-Analysis
. 2021 Jun:87:155-161.
doi: 10.1016/j.parkreldis.2021.04.019. Epub 2021 Apr 24.

Parkinson's disease may worsen outcomes from coronavirus disease 2019 (COVID-19) pneumonia in hospitalized patients: A systematic review, meta-analysis, and meta-regression

Affiliations
Meta-Analysis

Parkinson's disease may worsen outcomes from coronavirus disease 2019 (COVID-19) pneumonia in hospitalized patients: A systematic review, meta-analysis, and meta-regression

Cynthia Putri et al. Parkinsonism Relat Disord. 2021 Jun.

Abstract

Background: Parkinson's Disease (PD) is among one of the common comorbidities in older patients. People with PD may be more vulnerable to severe pneumonia, due to the impairment of pulmonary function. Currently, the association between PD and COVID-19 is not yet established. This study aims to analyze the relationship between PD and in-hospital outcomes of COVID-19.

Materials and methods: We systematically searched the PubMed and Europe PMC database using specific keywords related to our aims until December 25th, 2020. All articles published on COVID-19 and Parkinson's Disease were retrieved. The quality of the study was assessed using the Newcastle Ottawa Scale (NOS) tool for observational studies and Joanna Briggs Institute (JBI) Critical Appraisal Tools for cross-sectional studies. Statistical analysis was done using Review Manager 5.4 software.

Results: A total of 12 studies with 103,874 COVID-19 patients were included in this meta-analysis. This meta-analysis showed that Parkinson's Disease was associated with poor in-hospital outcomes [[OR 2.64 (95% CI 1.75-3.99), p < 0.00001, I2 = 81%] and its subgroup which comprised of severe COVID-19 [OR 2.61 (95% CI 1.98-3.43), p < 0.00001, I2 = 0%] and mortality from COVID-19 [RR 2.63 (95% CI 1.50-4.60), p = 0.0007, I2 = 91%]. Meta-regression showed that the association was influenced by age (p = 0.05), but not by gender (p = 0.46) and dementia (p = 0.23).

Conclusions: Extra care and close monitoring should be provided to Parkinson's Disease patients to minimize the risk of infections, preventing the development of severe and mortality outcomes.

Keywords: COVID-19; Coronavirus disease 2019; Movement disorder; Neurologic disease; Parkinson's disease.

PubMed Disclaimer

Conflict of interest statement

None.

Figures

Fig. 1
Fig. 1
PRISMA diagram of the detailed process of selection of studies for inclusion in the systematic review and meta-analysis.
Fig. 2
Fig. 2
(A) Forest plot that demonstrates the association of Parkinson's Disease with in-hospital outcomes and its subgroup which comprises of severe COVID-19 and mortality. (B). Sensitivity analysis performed by removing study by Rutten JJS et al. and Zhang Q et al. which cause significant heterogeneity still showed significant association between Parkinson's Disease with in-hospital outcomes of COVID-19.
Fig. 3
Fig. 3
Bubble-plot for Meta-regression. Meta-regression analysis showed that the association between Parkinson's Disease and in-hospital outcomes was affected by age [A], but not by gender [B] and dementia [C].
Fig. 4
Fig. 4
Funnel plot analysis for the association of Parkinson's Disease with in-hospital outcomes and its subgroup which comprises of severe COVID-19 and mortality.

Similar articles

Cited by

References

    1. World Health Organization Coronavirus disease (COVID-19): weekly epidemiological update – 22 December 2020. 2020. https://www.who.int/publications/m/item/weekly-epidemiological-update---...
    1. Hariyanto T.I., Rizki N.A., Kurniawan A. Anosmia/hyposmia is a good predictor of coronavirus disease 2019 (COVID-19) infection: a meta-analysis. Int. Arch. Otorhinolaryngol. 2020 doi: 10.1055/s-0040-1719120. 10.1055/s-0040-1719120. - DOI - PMC - PubMed
    1. Hariyanto T.I., Kristine E., Jillian Hardi C., Kurniawan A. Efficacy of lopinavir/ritonavir compared with standard care for treatment of coronavirus disease 2019 (COVID-19): a systematic review. Infect. Disord. - Drug Targets. 2020 doi: 10.2174/1871526520666201029125725. - DOI - PubMed
    1. Gold M.S., Sehayek D., Gabrielli S., Zhang X., McCusker C., Ben-Shoshan M. COVID-19 and comorbidities: a systematic review and meta-analysis. Postgrad. Med. 2020;132(8):749–755. doi: 10.1080/00325481.2020.1786964. - DOI - PubMed
    1. Hariyanto T.I., Kurniawan A. Anemia is associated with severe coronavirus disease 2019 (COVID-19) infection. Transfus. Apher. Sci. 2020:102926. doi: 10.1016/j.transci.2020.102926. - DOI - PMC - PubMed